Synedica Retatrutide Pens
£120.00
Storage Instructions
Store refrigerated at 2–8°C. Do not freeze. Protect from light.
Description
Third-party manufactured Retatrutide pre-filled research pen produced by Synedica. Retatrutide is a triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors. This pen format provides precise, repeatable dispensing for controlled laboratory research applications.
Research Context
Retatrutide has been studied in preclinical models examining triple incretin receptor agonism. This Synedica-manufactured pen format is designed for laboratory research workflows requiring consistent and reproducible dispensing. Supplied exclusively for in vitro laboratory research purposes.
Reconstitution Guide
Open the calculator pre-loaded with this compound to plan reconstitution.
Related Research
Research guides for this compound are coming soon. Browse our full library at /guides.
Related Products
This product is supplied for in-vitro laboratory research only. Not for human consumption, medical treatment, or cosmetic use.
Disclaimer for Elv8 Wellness Purchase
By purchasing from Elv8 Wellness, you acknowledge and agree that:
- Research Use Only: All products are exclusively sold for research purposes. They are not intended for human use, therapeutic, diagnostic, or clinical application.
- Not Medical Products: None of the products listed on our website are medical products, nor should they be marketed or used as such.
- Compliance and Responsibility: The buyer is responsible for ensuring compliance with all relevant laws and regulations. Elv8 Wellness holds no liability for misuse of products or any adverse outcomes.
Your purchase signifies your understanding and agreement to these terms.